Hyperliquid Strategies INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
Hyperliquid Strategies Inc. has entered into a new executive placement agreement for its COO and amended its CEO's employment contract.
Hyperliquid Strategies Inc. reported a significant net loss for Q2 2025, primarily driven by unrealized losses on HYPE tokens, despite strong balance sheet and strategic capital deployment.
Hyperliquid Strategies Inc. announced a new stock repurchase program of up to $30 million, aiming to enhance shareholder value by increasing per-share exposure to the HYPE token.
Hyperliquid Strategies Inc. has completed its business combination with Sonnet BioTherapeutics and Rorschach I LLC, pivoting to a digital asset treasury model focused on the HYPE token and listing on Nasdaq under 'PURR'.